Nihon Kohden Corporation
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 7 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Major Holders
Updated 2026/01/11| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
First Eagle Funds-First Eagle Overseas Fund
|
6.2M | +7.47% | |
|
VANGUARD TRUSTEES' EQUITY FUND-Vanguard International Value Fund
|
3.4M | -3.70% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
2.3M | +1.72% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
1.5M | +4.81% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
1.1M | +0.91% | |
|
iShares Trust-iShares MSCI EAFE Small-Cap ETF
|
522.0K | +4.63% |
Dividend History 1Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥32 | +4.9% |
| 2024 | ¥31 | -14.1% |
| 2023 | ¥36 | +4.4% |
| 2022 | ¥34 | +19.3% |
| 2021 | ¥29 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥205,129M | ¥206,603M | ¥221,986M | ¥225,424M |
| Gross Profit | ¥109,085M | ¥105,926M | ¥111,346M | ¥117,157M |
| Operating Income | ¥30,992M | ¥21,121M | ¥19,591M | ¥20,713M |
| Pretax Income | ¥34,274M | ¥24,726M | ¥29,393M | ¥21,714M |
| Net Income | ¥23,435M | ¥17,110M | ¥17,026M | ¥14,098M |
| EPS | ¥138.25 | ¥101.64 | ¥101.22 | - |
| Operating Margin | 15.11% | 10.22% | 8.83% | 9.19% |
| Balance Sheet | ||||
| Total Assets | ¥210,201M | ¥216,728M | ¥233,233M | ¥258,276M |
| Total Equity | ¥156,378M | ¥167,602M | ¥181,080M | ¥179,550M |
| Total Liabilities | ¥53,823M | ¥49,126M | ¥52,153M | ¥78,726M |
| Cash | ¥28,925M | ¥33,459M | ¥36,132M | ¥28,428M |
| Interest-bearing Debt | ¥359M | ¥441M | ¥654M | ¥26,076M |
| Equity Ratio | 74.39% | 77.33% | 77.64% | 69.52% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.15 |
| Cash Flow | ||||
| Operating CF | ¥25,699M | -¥2,513M | ¥15,607M | ¥15,286M |
| Investing CF | -¥4,303M | -¥7,647M | -¥5,208M | -¥25,138M |
| Financing CF | -¥7,300M | -¥7,485M | -¥6,968M | ¥2,550M |
| Free CF | ¥22,765M | -¥10,769M | ¥10,821M | ¥6,577M |
| Efficiency | ||||
| ROE | 14.99% | 10.21% | 9.40% | 7.85% |
| ROA | 11.15% | 7.89% | 7.30% | 5.46% |
Latest IR Information
-
Notice Regarding Acquisition of Shares in Dwell Co., Ltd.
Nihon Kohden Corporation acquires shares of Dwell Co., Ltd., making it a consolidated subsidiary. Post-acquisition shareholding ratio: Nihon Kohden 90.3%, Yoshihiro Shindo 9.7%. Share acquisition execution is scheduled for February 27, 2026.
Read more -
Notice Regarding the Status of Treasury Stock Acquisition (Based on the Provisions of Article 165, Paragraph 2 of the Companies Act)
Completed acquisition of 718,200 shares of treasury stock totaling 1,107,823,500 yen from December 4 to December 31, 2025.
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥2,109
Rating Score: - (Based on 7 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Nihon Kohden Corporation engages in research and development, production, sales, and repair and maintenance of medical electronic equipment in Japan, North America, Latin America, Europe, Asia, and internationally. It offers physiological measuring equipment, such as electroencephalographs, evoked potential and electromyogram measuring systems, electrocardiographs, polygraphs for Cath lab, diagnostic information systems, recording paper, electrodes, and EP catheters. The company also provides patient monitors such as central monitors, bedside monitors, wireless monitors, remote access software and other equipment, clinical information systems, and electrodes and sensors. In addition, it offers Defibrillators, AEDs, ventilators, pacemakers, anesthesia machines, cochlear implants, automated chest compression devices, AED pads, batteries, and ablation catheters; hematology analyzers, clinical chemistry analyzers, ultrasound diagnostic equipment and others, consumables, including test reagents, and installation and maintenance services. Further, it is involved in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
